You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A COMPUTER-BASED YOUTH SUBSTANCE ABUSE TRAINING PROGRAM
SBC: Constructive Solutions, Inc. Topic: N/ATHE LONG-TERM OBJECTIVE IS TO DEVELOP A COMPUTER-BASED YOUTH SUBSTANCE ABUSE FITNESS LIFE SKILLS TRAINING PRODUCT FOR HEALTH PROFESSIONALS, USING STATE-FO-THE-ART HARDWARE AND SOFTWARE TECHNOLGOY. A SYSTEMATIC CURRICULUM REQUIRING SIXTY-FOUR HOURS OF CLASSROOM TRAINING HAS BEEN DEVELOPED FOR HEALTH PROFESSIONALS TO DELIVER THE FITNESS LIFE SKILLS MODEL. HOWEVER, THE LENGTH AND EXPENSE REQUIRED TO ...
SBIR Phase I 1992 Department of Health and Human Services -
A GENERAL DATA ENTRY/REPORTING SYSTEM FOR ADOPTION/FOSTER CARE DATA
SBC: Austin Data Management Associa Topic: N/AN/A
SBIR Phase I 1992 Department of Health and Human Services -
AN INTEGRALLY CAST ASPHERIC READING OR BIOPTIC TELESCOPE
SBC: L. A. Spitzberg, Inc. Topic: N/AN/A
SBIR Phase I 1992 Department of Health and Human Services -
AN OCULAR NEUROTROPHIC FACTOR TO TREAT GLAUCOMA
SBC: Houston Biotechnology, Inc. Topic: N/ATHE CILIARY GANGLION INNERVATES SEVERAL IMPORTANT EYE TISSUES, INCLUDING THE CILIARY MUSCLE AND BODY, AND HAS BEEN SHOWN TO REGULATE AQUEOUS OUTFLOW AND ACCOMMODATION. THE EYE DISORDERS, GLAUCOMA AND PRESBYOPIA, MAY INVOLVE THE CILIARY GANGLION THROUGH ITS REGULATION OF AQUEOUS OUTFLOW AND VISUAL ACCOMMODATION. A SUBSTANCE THAT COULD DIRECTLY AND SPECIFICALLY STIMULATE THE CILIARY GANGLION MAY BE ...
SBIR Phase II 1992 Department of Health and Human Services -
ANTI HIV-1 ACTIVITY OF TRIPLEX FORMING OLIGNUCLEOTIDES
SBC: Triplex Pharmaceutical Topic: N/AANTIVIRAL AGENTS FOR THE TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) ARE DEARLY IN GREAT NEED. WE HAVE SYNTHESIZED AND DONE PRELIMINARY EXPERIMENTS WITH A TRIPLE HELIX FORMING OLIGONUCLEOTIDE DESIGNED TO BIND TO CRITICAL REGULATORY REGIONS IN THE PROVIRAL GENOME OF HIV-1. PRELIMINARY DATA SHOW THAT COMPOUND INHIBITS VIRAL P24 PRODUCTION IN A CHRONICALLY INFECTED MONOCYTE CELL LINE. THE PRIM ...
SBIR Phase I 1992 Department of Health and Human Services -
A URINE TEST TO DETECT KIDNEY TRANSPLANT REJECTION
SBC: Biomedical Development Corporation Topic: N/AIMMUNOLOGIC REJECTION IS THE LEADING CAUSE OF FAILURE OF RENAL TRANSPLANTATION. THE OBJECTIVE WILL BE TO DEVELOP AN ASSAY FOR MONITORING KIDNEY TRANSPLANT RECIPIENTS FOR THE ONSET OF GRAFT REJECTION AND TO HELP DISTIGUISH GRAFT REJECTION FROM OTHER RENAL AND EXTRARENAL PROBLEMS IN THESE PATIENTS. SINCE IMMUNOLOGIC ATTACK ON THE RENAL TUBULES IS THE PRIMARY CAUSE OF REJECTION, AN ASSAY THAT MEASURE ...
SBIR Phase I 1992 Department of Health and Human Services -
AUTOMATED HOME TABLET AND CAPSULE DISPENSER
SBC: Checkmate Engineering Topic: N/AOF 28 MILLION AMERICANS OVER AGE 65, 8.5 MILLION LIVE ALONE. MORE THAN 50 PERCENT SUFFER FROM SUCH CHRONIC AILMENTS AS ARTHRITIS, HYPERTENSION, AND HEART DISEASE, ALL OFTEN REQUIRING DAILY MEDICATION. U.S. PUBLIC HEALTH RECORDS ESTIMATE THAT 125,000 DEATHS OCCUR EACH YEAR FROM THE MISUSE OF CARDIOVASCULAR DRUGS ALONE, AND THAT ONE IN EVERY TWO PATIENTS TAKING MEDICINE REGULARLY MAKES ERRORS SUFFIC ...
SBIR Phase II 1992 Department of Health and Human Services -
AUTOMATED THERAPY MONITORING IN LEUKEMIA CYTOGENETICS
SBC: Perceptive Sciences Topic: N/AN/A
SBIR Phase I 1992 Department of Health and Human Services -
COLD STERILANT FOR DELICATE MEDICAL INSTRUMENTS
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1992 Department of Health and Human Services -
CONSTRUCTION OF CHICKEN X MOUSE HYBRIDOMAS
SBC: Houston Biotechnology, Inc. Topic: N/AWE WILL CONSTRUCT CHICKEN KH MOUSE HYBRIDOMA CELL LINES SECRETING CHICKEN MABS TO SELECTED ANTIGENS. A PRIMARY ADVANTAGE IN THE CONSTRUCTION OF THESE HYBRIDOMAS IS THE GENETIC DIFFERENCES BETWEEN CHICKENS AND MAMMALS WHICH INCREASES THE CHANCE OF PRODUCING ANTIBODIES AGAINST HIGHLY CONSERVED REGIONS OF MAMMALIAN PROTEINS SUCH AS PEPTIDE HORMONES AND GROWTH FACTORS. BECAUSE OF THIS GENETIC DIFFEREN ...
SBIR Phase I 1992 Department of Health and Human Services